Limb salvage in musculoskeletal oncology

Lancet Oncology

Volumn 4, Issue 6, 2003, Pages 343-350

  Veth, René P H ^a   van Hoesel, René ^a   Pruszczynski, Maciej ^a   Hoogenhout, Jaap ^a   Schreuder, Bart ^a   Wobbes, Theo ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE;

BONE TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOMYOPATHY; CLINICAL TRIAL; ESTHETICS; EWING SARCOMA; FUNCTIONAL ASSESSMENT; HEART FAILURE; HUMAN; LIMB AMPUTATION; LIMB SALVAGE; MALE INFERTILITY; MALIGNANT NEOPLASTIC DISEASE; MUSCLE TUMOR; OSTEOSARCOMA; PATHOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SALVAGE THERAPY; SKILL; SURGICAL TECHNIQUE; TUMOR BIOPSY; DRUG THERAPY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PROSTHESES AND ORTHOSES; RADIOTHERAPY;

BONE NEOPLASMS; COMBINED MODALITY THERAPY; DRUG THERAPY; HUMANS; LIMB SALVAGE; MUSCLE NEOPLASMS; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROSTHESES AND IMPLANTS; RADIOTHERAPY;

EID: 0038747957     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(03)01114-8     Document Type: Review

References (71)

1. Veth RPH, van Hoesel QGCM, Bokkerink JPM, et al. The art of limb salvage in musculoskeletal oncology. Crit Rev Oncol Hematol 1995; 21: 77-103.
2. Ottolenghi CE. Massive osteo and ostearticular bone grafts: technique and results of 62 cases. Clin Orthop 1972; 87: 156-64.
3. Mankin HJ, Fogelson FS, Thrasher AZ, et al. Massive resection and allograft replacement in the treatment of malignant bone tumours. N Engl J Med 1976; 294: 1247-55.
4. Pho RWA. Free vascularised fibular transplant for replacement of lower radius. J Bone Joint Surg 1979; 6IB: 362-65.
5. Seeger LL, Gold RH, Chandnani VP. Diagnostic imaging of osteosarcoma. Clin Orthop Rel Res 1991; 270: 254-64.
6. Levine E, Lee KR, Heff JR, et al. Comparison of computed tomography and other imaging modalities in the evaluation of musculoskeletal tumours. Radiology 1979; 131: 431-37.
7. Manfield P, Mandley AA. Medical imaging by NMR. Br J Radiol 1977; 60: 188-94.
8. Rosen G. Ewing sarcoma: 100 year experience with adjuvant chemotherapy. Cancer 1981; 47: 2204.
9. Rosen G, Caparros B, Huvos AG, et al. Pre-operative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response to pre-operative chemotherapy. Cancer 1982; 49: 1221-30.
10. Suit HD, Mankin HJ, Schiller AL, et al. Results of treatment of sarcoma of soft tissue by radiation and surgery at Massachusetts General Hospital. Cancer Treat Symp 1985; 3: 43-47.
11. Suit HD, Mankin HJ, Wood WC, et al. Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer 1985; 55: 2659-67.
12. Enneking WF. A system for staging muscoloskeletal neoplasms. Clin Orthop 1986; 204: 9-24.
13. American Joint Committee on Cancer. Manual for staging of cancer. Beahrs OH, Henson DE, Hutter RV, et al (Eds). Philadelphia: Lippincott, 1992: 127-37.
14. Simon MA, Finn HA. Diagnostic strategy for bone and soft tissue tumours. J Bone Joint Surg 1993; 75A: 622-32.
15. Souhami RL, Craft RL, Van der Eijken JW. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997; 350: 911-17.
16. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 protocol: an updated report. J Clin Oncol 2000; 18: 4016-27.
17. Meyer WH, Pratt CB, Poquette CA, et al. Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. J Clin Oncol 2001; 19: 171-82.
18. Akatsuka T, Wada T, Kokai Y, et al. ErbB2 expression is correlated with increased survival of patients with osteosarcoma. Cancer 2002; 94: 1397-404.
19. Gorlick R, Huvos AG, Heller G, et al. Expression of HER2/erB-2 correlates with survival in osteosarcoma. J Clin Oncol 1999; 17: 2781-88.
20. Paulussen M, Ahrens S, Dunst J, et al. Localized Ewing tumor of bone: final results of the Cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 2001; 19: 1818-29.
21. Bacci G, Picci P, Ferrari S, et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone. Cancer 1998; 82: 1174-83.
22. Carol MP, Woo SY, Butler EB, et al. Intensity modulated radiation therapy treatment. In: Tobias JS, Thomas PRM (Eds). Current radiation oncology. London: Arnold, 1998: 376-95.
23. Teh BS, Woo SY, Butler EB. Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology. Oncologist 1999; 4: 433.
24. Dunst J, Jurgens H, Sauer R, et al. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys 1995; 32: 919-30.
25. Sarcomas of soft tissues and bones. In: De Vita Jr VT, Hellman S, Rosenberg SA (Eds). Cancer principles and practice of oncology, 6th edn. Philadelphia: Lippincott Wililiams & Wilkins, 2001: 1840-935.
26. Pisters WT, Harrison LB, Leung DHY, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996; 14: 859.
27. Kuttesch JF Jr, Wexler LH, Marcus RB, et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996; 14: 2818-25.
28. Enneking WF, Dunham W, Gebhardt M, et al. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumours of the musculoskeletal system. Clin Orthop 1993; 286: 241.
29. Davis AM, Wright JG, Williams JI, et al. Development of a measure of function for patients with bone and soft tissue sarcoma. Qual Life Res 1996; 5: 508-16.
30. Gebhardt MC. What's new in musculoskeletal oncology. J Bone Joint Surg 2002; 84A: 694-701.
31. Enzinger FM, Weiss SW. General considerations. In: Weiss SW, Goldblum JR (Eds). Soft tissue tumors, 4th edn. St Louis: Mosby, 2001: 1-21.
32. Oliveira AM, Nascimento AG. Grading in soft tissue tumors: principles and problems. Skeletal Radiol 2001; 30: 543-59.
33. Costa J, Wesley RA, Glatstein E, et al. The grading of soft tissue sarcomas: result of a clinicopathologic correlation in a series of 163 cases. Cancer 1984; 53: 530-41.
34. Trojani M, Contesso G, Coindre JM, et al. Soft tissue sarcomas of adults: study of pathologic prognostic variables and definition of a histopathological grading system. Int J Cancer 1984; 33: 37-42.
35. Arbiser ZK, Folpe AL, Weiss SW. Consultative/expert opinions in soft tissue pathology: analysis of problem-prone diagnostic situation. Am J Clin Pathol 2001; 116: 473-76.
36. Jensen V, Sorensen FB, Bentzen SM, et al. Proliferative activity/MIB1 index is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistochemical study including 216 soft tissue sarcomas. Histopathology 1998; 32: 536-46.
37. Rizzo M, Ghert MA, Harrelson JM, et al. Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictor of outcome. Clin Orthop 2001; 391: 224-33.
38. Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYT-SSX fusion type on the clinical behaviour of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 2002; 62: 135-40.
39. Gustafson P. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients. Cytometry 2002; 50: 19-24.
40. Kusuzaki K, Murata H, Takeshita K, et al. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas. Mod Pathol 1999; 12: 863-72.
41. Simon MA, Biermann J. Biopsy of bone and soft tissue lesions. J Bone Joint Surg 1993; 75A: 616-21.
42. Hackbarth DA. Resections and reconstructions for tumours of the distal radius. Orthop Clin North Am 1991; 22: 49-65.
43. Sperling JW, Pritchard DJ, Morrey BF: Total elbow arthroplasty after resection of tumors at the elbow. Clin Orthop 1999; 367: 256-61.
44. Eckardt JJ, Eilber FR, Rosen G, et al. Endoprosthetic replacement for stage IIB osteosarcoma. Clin Orthop Rel Res 1991; 270: 202-14.
45. Malawer MM, Sugarbaker PH. Shoulder girdle resection: the Tikhoff Limberg procedure and its modifications. In: Sugarbaker PH (Ed). Surgery in musculoskeletal cancer. New York: Thieme Verlag, 1992: 346-61.
46. Malawer MM, Wittig J, Rubert C. Scapulectomy. In: Malawer MM, Sugarbaker PH (Eds). Musculoskeletal cancer surgery. Dordrecht: Kluwer Academic Publishers, 2001: 554-68.
47. Sundaresan N, Schiller AL, Rosenthal DI. Osteosarcoma of the spine. In: Sundaresan N (Ed). Tumours of the spine. Philadelphia: WB Saunders, 1990: 128-45.
48. Enneking WF, Dunham WK. Resection and reconstruction for primary neoplasms involving the innominate bone. J Bone Joint Surg 1978; 60A: 731-46.
49. Campanacci M, Capanna R. Pelvic resections, the Rizzoli Institute experience. Orthop Clin North Am 1991; 22: 65-87.
50. Renard AJS, Veth RPH, Schreuder HWB, et al. The saddle prosthesis in pelvic primary and secundary tumors: functional results at several postoperative intervals. Arch Orthop Traum Surg 2000; 120: 188-94.
51. Samson IB, Springfield DS, Suit HS, Mankin HJ. Operative treatment of sacrococcygeal chordome. J Bone Joint Surg 1993; 75A: 1476-84.
52. Grimer RJ, Belthur M, Carter SL, et al. Extendable replacements of the proximal tibia for bone tumours. J Bone Joint Surg 2000; 82: 255-26.
53. Verkerke GJ, Schraffordt Koops H, Veth RPH, et al. First clinical experience with a non-invasively extendable endoprosthesis. Artif Organs 1997; 5: 413-17.
54. Dubousset J, Missenard G. Reconstruction of quadriceps insertion by aponeurotic and muscular plasties after proximal tibial replacement in osteogenic sarcoma. In: Kotz R (Ed). Proceedings of the Second International Workshop on the Design and Application of Tumour Prostheses for Bone and Joint Reconstruction. Vienna: Egermann, 1983: 275-77.
55. Eggermont AMM, Schraffordt Koops H, Klausner JM, et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. Ann Surg 1996; 224: 756-65.
56. Olieman AFT, Van Ginkel RJ, Hoekstra HJ, et al. Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor. Ann Surg Oncol 1997; 4: 64-69.
57. Nakano H, Tateishi A, Miki H, et al. Hyperthermic isolated regional perfusion for the treatment of osteosarcoma in the lower extremity. Am J Surg 1999; 178: 27-32.
58. National Institutes of Health. Limb-sparing treatment of soft tissue sarcomas and osteosarcomas. Consensus development, vol 5, no 6. Bethesda, MD: NIH, 1984.
59. de Visser E, Mulder T, Schreuder HWB, et al. Gait and electromyographic analysis of patients recovering after limbsaving surgery. Clin Biomech 2000; 15: 592-99.
60. Sugarbaker PH, Barofski I, Rosenberg SA, et al. Quality of life assessment of patients with extremity sarcoma. Surgery 1987; 91: 17-23.
61. Postma A, Kingma A, Veth RPH, et al. Quality of life in bone tumour patients comparing limb-salvage and amputation of the lower extremity. J Surg Oncol 1987; 51: 47-51.
62. Van der Geest ICM, Servaes P, Schreuder HWB, et al. Chondrosarcoma of bone: functional outcome and quality of life. J Surg Oncol 2002; 81: 70-74.
63. Ruggieri P, De Cristofaro R, Picci P, et al. Complications and surgical indications in 144 cases of non-metastatic osteosarcoma of the extremities, treated with neoadjuvant chemotherapy. Clin Orthop 1993; 295: 226-38.
64. Renard AJS, Veth RPH, Schreuder HWB, et al. Function and complications after ablative and limb salvage therapy in lower extremity sarcoma of bone. J Surg Oncol 2000; 73: 198-205.
65. Renard AJS, Veth RPH, Schreuder HWB, et al. Revisions of endoprosthetic reconstructions after limb salvage in musculoskeletal oncology. Arch Orthop Traum Surg 1998; 117: 125-31.
66. Grimer RJ, Belthur M, Chandrasekar C, et al. Two-stage revision for infected endoprostheses used in tumor surgery. Clin Orthop 2002; 395: 193-203.
67. Dion N, Sim FH. The use of allografts in musculoskeletal oncology. J Bone Joint Surg 2002; 84A: 644-55.
68. Kremer LC, van Dalen EC, Offringa M, et al. Anthracycline-induced heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol 2001; 19: 191-96.
69. Arndt C, Morgenstern B, Hawkins D, et al. Renal function following chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma. Med Pediatr Oncol 1999; 32: 93-96.
70. Longhi A, Porcu E, Petracchi S, et al. Reproductive functions in female patients treated with adjuvant and neoadjuvant chemotherapy for localized osteosarcoma of the extremity. Cancer 2000; 89: 1961-65.
71. Frieden RA, Ryniker D, Kenan S, et al. Assessment of patient function after limb sparing surgery. Arch Phys Med Rehabil 1993; 74: 38-43.